Pacific Point Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1M Hold
10,000
0.58% 62
2025
Q4
$1.66M Buy
10,000
+1,500
+18% +$251K 0.89% 25
2025
Q3
$1.66M Sell
8,500
-1,500
-15% -$247K 0.97% 25
2025
Q2
$904K Buy
10,000
+3,000
+43% +$237K 0.49% 55
2025
Q1
$418K Buy
7,000
+3,000
+75% +$278K 0.23% 86
2024
Q4
$530K Buy
+4,000
New +$375K 0.32% 74

Other funds holding ALAB

Pacific Point Advisors's ALAB Position: Q1 2026 in Review

Pacific Point Advisors held its Astera Labs (ALAB) position steady in Q1 2026 at 10,000 shares worth $1.1M. The position accounts for 0.58% of the portfolio, ranked #62.

Pacific Point Advisors first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.66M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Pacific Point Advisors held 10,000 shares of Astera Labs worth $1.1M as of Q1 2026.
  • Pacific Point Advisors left its Astera Labs share count unchanged in Q1 2026.
  • Astera Labs made up 0.58% of Pacific Point Advisors's portfolio in Q1 2026, its #62 holding.
  • Pacific Point Advisors first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • Pacific Point Advisors's Astera Labs position peaked at $1.66M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Pacific Point Advisors's 13F filing for Q1 2026, filed 4 May 2026.